Russell Investments Group
TXG icon

Russell Investments Group’s 10x Genomics TXG Stock Holding History

Russell Investments Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6M Buy
564,307
+83,688
+17% +$2.19M 0.02% 713
2026
Q1 		$10.2M Sell
480,619
-53,328
-10% -$1.07M 0.01% 931
2025
Q4 		$8.71M Sell
533,947
-33,737
-6% -$510K 0.01% 1003
2025
Q3 		$6.64M Sell
567,684
-71,161
-11% -$928K 0.01% 1140
2025
Q2 		$7.4M Buy
638,845
+557,176
+682% +$5.08M 0.01% 991
2025
Q1 		$713K Buy
81,669
+64,851
+386% +$817K ﹤0.01% 2172
2024
Q4 		$242K Buy
16,818
+6,932
+70% +$109K ﹤0.01% 2494
2024
Q3 		$223K Sell
9,886
-137,579
-93% -$2.84M ﹤0.01% 2486
2024
Q2 		$2.87M Buy
147,465
+1,021
+0.7% +$26.7K ﹤0.01% 1451
2024
Q1 		$5.5M Buy
146,444
+134,598
+1,136% +$5.91M 0.01% 1125
2023
Q4 		$663K Sell
11,846
-48
-0.4% -$2.09K ﹤0.01% 2126
2023
Q3 		$491K Sell
11,894
-13,842
-54% -$720K ﹤0.01% 2231
2023
Q2 		$1.44M Sell
25,736
-5,422
-17% -$293K ﹤0.01% 1739
2023
Q1 		$1.74M Buy
31,158
+880
+3% +$41.1K ﹤0.01% 1670
2022
Q4 		$1.1M Buy
30,278
+28,100
+1,290% +$919K ﹤0.01% 1922
2022
Q3 		$61K Sell
2,178
-352,303
-99% -$13.4M ﹤0.01% 2727
2022
Q2 		$16M Sell
354,481
-24,276
-6% -$1.26M 0.03% 585
2022
Q1 		$28.8M Buy
378,757
+130,149
+52% +$11.4M 0.05% 443
2021
Q4 		$37M Sell
248,608
-28,942
-10% -$4.43M 0.06% 384
2021
Q3 		$40.4M Sell
277,550
-5,494
-2% -$943K 0.07% 350
2021
Q2 		$55.4M Buy
283,044
+24,598
+10% +$4.45M 0.09% 258
2021
Q1 		$46.8M Buy
258,446
+251,583
+3,666% +$43.4M 0.08% 294
2020
Q4 		$973K Buy
+6,863
New +$996K ﹤0.01% 2128
2020
Q3 		– Sell
-5,121
Closed -$457K – 3258
2020
Q2 		$457K Buy
5,121
+3,199
+166% +$249K ﹤0.01% 2408
2020
Q1 		$119K Buy
+1,922
New +$150K ﹤0.01% 2683

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Russell Investments Group's TXG Position: Q2 2026 in Review

Russell Investments Group increased its 10x Genomics (TXG) stake by 17% in Q2 2026, buying an estimated $2.19M and bringing the position to 564,307 shares worth $21.6M. The position accounts for 0.02% of the portfolio, ranked #713.

Russell Investments Group first reported a position in TXG in Q1 2020 and has held it in 25 quarters since. The position peaked at $55.4M in Q2 2021. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Russell Investments Group held 564,307 shares of 10x Genomics worth $21.6M as of Q2 2026.
  • Russell Investments Group bought 83,688 10x Genomics shares in Q2 2026, an estimated $2.19M.
  • 10x Genomics made up 0.02% of Russell Investments Group's portfolio in Q2 2026, its #713 holding.
  • Russell Investments Group first reported a position in 10x Genomics in Q1 2020 and has held it in 25 quarters since.
  • Russell Investments Group's 10x Genomics position peaked at $55.4M in Q2 2021.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.